Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
6
Number of overlapping holdings
26.1%
% of THNR's 23 holdings also in PPH
25.0%
% of PPH's 27 holdings also in THNR
Overlap by Weight
Sector Drift (THNR minus PPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in THNR |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 15.7% | 11.7% | 11.7% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.0% | 4.9% | 4.9% |
 |
NOVO-NORDISK A/S-SPONS ADR | 14.7% | 4.8% | 4.8% |
|
MERCK & CO. INC. | 4.8% | 4.7% | 4.7% |
|
PFIZER INC | 4.9% | 4.3% | 4.3% |
Position Highlights (Non-Overlapping Exposures)
THNR Overweight Relative to PPH
|
NOVO-NORDISK A/S-SPONS ADR | 9.9% |
 |
INNOVENT BIOLOGICS, INC. | 5.6% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 5.5% |
|
WEST PHARMACEUTICAL SERVICES | 5.4% |
|
AMGEN INC | 5.2% |
 |
ROCHE HOLDING LTD | 5.0% |
|
THERMO FISHER SCIENTIFIC INC | 5.0% |
|
ELI LILLY & CO | 4.1% |
|
HIMS & HERS HEALTH, INC. CLASS A | 3.8% |
|
MITSUBISHI CHEMICAL HOLDINGS | 3.4% |
THNR Underweight Relative to PPH
|
JOHNSON & JOHNSON | -6.7% |
|
ABBVIE INC | -6.2% |
|
CENCORA INC | -5.6% |
|
NOVARTIS AG-ADR | -5.5% |
|
MCKESSON CORP | -5.4% |
 |
SANOFI-AVENTIS-ADR | -5.0% |
|
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -4.6% |
|
ZOETIS INC | -4.6% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -4.5% |
|
BRISTOL-MYERS SQUIBB CO | -4.2% |